-
Simultaneous Liver Venous Deprivation Following Hepatic Arterial Chemoembolization Before Major Hepatectomy for Hepatocellular Carcinoma: A New Methods to Achieve Hypertrophy Liver Remnant
05 Feb 2025 07:16 GMT
… for patients with hepatocellular carcinoma (HCC); however, … strategy in treating HCC patients, particularly … of hepatoprotective treatment, patients exhibited … trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma …
-
Opdivo Receives Positive CHMP Opinion for Hepatocellular Carcinoma
05 Feb 2025 01:04 GMT
… treatment of adult patients with unresectable or advanced hepatocellular carcinoma (HCC … ), based on results from the Phase 3 CheckMate -9DW trial … the U.S. FDA also accepted the … offers
from American Pharmaceutical Review – all …
-
Imfinzi recommended for approval in European Union for the treat of adults with limited-stage small cell lung cancer
04 Feb 2025 22:22 GMT
… multi-centre global phase III trial evaluating Imfinzi monotherapy and Imfinzi … combination with Imjudo in unresectable hepatocellular carcinoma (HCC). Imfinzi is also approved as … broad development programme, Imfinzi is being tested as a single treatment and …
-
EMA’s CHMP recommends approval of Bristol Myers Squibb’s HCC treatment combo
03 Feb 2025 11:36 GMT
… first-line treatment of unresectable or advanced hepatocellular carcinoma (HCC) in … III CheckMate -9DW trial.
According to the … HCC was accepted by the US Food and Drug Administration (FDA).
A Prescription Drug … II CheckMate -040 trial.
A programmed death-1 …
-
Liver Cancer Drugs Market To Achieve USD 2,332 Million By 2032, Powered By Innovative Treatments
04 Feb 2025 09:35 GMT
… hepatocellular carcinoma (HCC) being the most common type. Recent advancements in liver cancer drugs … Future Trends: Drug development is focusing on targeted therapies, combination treatments, immunotherapy, and …
-
Long-Term Analysis of Recurrence Beyond Milan Criteria Following Ablation of Solitary Early-Stage Hepatocellular Carcinoma ≤3 cm in Potentially Transplantable Patients: A Over 10-Year Survival Study
03 Feb 2025 05:03 GMT
… 80% of hepatocellular carcinoma (HCC) is attributed … hepatocellular carcinoma: an intent-to-treat … al. Treatment strategy for recurrent hepatocellular carcinoma: … hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, Phase 3 trial …
-
Interferon Real- World Treatment Patterns in PV
03 Feb 2025 19:35 GMT
Neoadjuvant Botensilimab Plus Balstilimab Yields High MPR Rates in CRC
Comparable Survival Outcomes Observed With Atezolizumab/Bevacizumab vs Tremelimumab/Durvalumab in First-Line HCC
Dr Mekhail on a Case Study of Early-Stage, Nonmetastatic Lung …
-
NK cell therapy opens new ways for treating advanced pancreatic cancer
03 Feb 2025 07:45 GMT
… an urgent need to develop new therapies to … a phase 2a clinical trial in hepatocellular carcinoma (HCC). An independent review … cancer clinical trials, to treat pancreatic cancer.
Professor … expected to provide new treatment possibilities for patients with …
-
Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a First-Line Treatment Option for Adult Patients with Unresectable or Advanced Hepatocellular Carcinoma
31 Jan 2025 12:21 GMT
… hepatocellular carcinoma (HCC), based on results from the Phase 3 CheckMate -9DW trial … Food and Drug Administration (FDA) approved … treatment of adult patients with hepatocellular carcinoma (HCC) … , development and commercialization of pharmaceutical products …
-
Can-Fite BioPharma to Present the Namodenoson Anti-Obesity Effect at BIO CEO & Investor Conference 2025
05 Feb 2025 12:00 GMT
… small molecule drugs that address … advanced clinical stage drug development Company with a … trial for hepatocellular carcinoma (HCC), a Phase IIb trial for the treatment … Drug Administration. Namodenoson has also shown proof of concept to potentially treat …
About
© 1995-2025